Sitagliptin
Sitagliptin is a pharmaceutical compound used as a laboratory reagent. It is a dipeptidyl peptidase-4 (DPP-4) inhibitor, which plays a role in glucose metabolism. The core function of Sitagliptin is to inhibit the DPP-4 enzyme, thereby affecting the regulation of blood glucose levels. Detailed information regarding its intended use or applications is not available.
Lab products found in correlation
2 protocols using sitagliptin
Pharmacological Modulation of GLP-1 and GLP-2
Sitagliptin-Target Protein Interaction
Firstly, the amino acid sequence of the target protein was searched by Uniprot database, and the sequence was imported into Expasy (
sitagliptin (HPLC ≥ 98%, Shanghai yuanye Bio-Technology Co., Ltd) was dissolved in DMSO (VWR) solution and diluted with PBS-P+ (GE Healthcare) solution to the desired compound concentration (1×PBS-P+, 5% DMSO). The affinity and kinetics of sitagliptin with the novel target protein were tested by LMW kinetics module in Biacore T200 Control Software, and extra wash after injection with 50% DMSO was added.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!